CIRS Agenda_2015

HTA and Market Access Programme Research

HTA Agency Performance Metrics

CIRS initiated an annual metrics programme in 2013 in partnership with participating agencies, to undertake comparative benchmarking of the HTA and coverage process for the review and approval of new pharmaceuticals. The objective of this programme is to provide a systematic framework for HTA and coverage bodies that enables between-agency comparisons using objective criteria to facilitate shared learning and the identification of best practices


  • Detailed agency-specific reports
  • Agency Discussion Meeting
  • Agency visits for discussion of bespoke analyses
HTA/coverage decision-making milestones

HTA/coverage decision-making milestones